Accurate funding, publications, postdoc and student information can be found at the group site.

Richard's research is motivated towards enabling a “panor-omic” view of patients through the integration of genomics data with data derived from patient records, the exposome, social graphs, remote monitoring and imaging to develop strategies for P4 medicine: medicine that is precise, predictive, preventative and participatory. The research has required the extensive use of computational approaches such as machine learning, the creation of software tools, development of a hospital development environments and large private cloud infrastructure with safe haven status to enable integration of patient datasets. The work has led to a rich portfolio of academic collaborations, some key ones include TwinsUK (http://www.twinsuk.ac.uk), HipSci, (http://www.hipsci.org), the Alzheimer’s Research UK Drug Discovery initiative (ARUK-O3DI; http://o3di.medsci.ox.ac.uk/), GENAROAD (http://goo.gl/840zfe), the Psychiatric Genomics Consortium (http://www.med.unc.edu/pgc) and The Center for Behavioural Intervention Technologies, Northwestern, Chicago (CBITS; http://goo.gl/ScNIxt).

His research has strong links with the technology and pharma industry, charities, and academia. Dobson sits on grant review panels & strategy groups, including the DoH 10-year strategy for Population & Health Services Research in mental health working group, Genomics England (EHR GeCIP co-lead), Canadian Foundation for Innovation, mental health charity MQ, NIHR and London GMCs. He is UCL and KCL’s informatics lead for several industrial and academic collaborations, including the EU IMI2 European Medical Information Framework (EMIF), IMI2 €22m Remote Assessment of Disease and Relapse (RADAR-cns.org), H2020 Kconnect (kconnect.eu), IMI2 BigData@Heart, Intel-Turing Institute collaboration, Lilly, UCB, Janssen, Biogen, GE, Intel, IBM, SoftwareAG, Michael J Fox Foundation, Vibrent (a major subcontractor to the US Precision Medicine Initiative)  and FitBit.